Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Nov 13, 2012 sing george l Director Sell 5,000 148.00
Nov 16, 2012 sing george l Director Sell 5,000 152.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Dec 17, 2012 sing george l Director Disposition (Non Open Market) 10,000 n/a
May 30, 2012 sing george l Director Sell 5,000 134.00
May 31, 2012 sing george l Director Sell 5,000 134.74 - 135.15
Jul 26, 2012 sing george l Director Sell 5,000 135.00
Jul 26, 2012 sing george l Director Option Execute 5,000 18.80
Aug 22, 2012 sing george l Director Sell 5,000 139.00
Aug 22, 2012 sing george l Director Option Execute 5,000 18.80
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
Nov 23, 2010 vagelos p roy Director Automatic Sell 30,000 30.03
Dec 16, 2010 vagelos p roy Director Automatic Sell 17,384 32.04
Dec 17, 2010 vagelos p roy Director Automatic Sell 12,616 32.06
Jan 3, 2011 vagelos p roy Director Automatic Sell 8,957 34.04
Showing 301-320 of 839 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)